Chemed (NYSE:CHE) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Chemed (NYSE:CHE) from a hold rating to a strong-buy rating in a research note released on Saturday.

Other research analysts also recently issued reports about the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Oppenheimer lifted their price target on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Royal Bank Of Canada boosted their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $530.75.

Chemed Trading Up 1.6%

Chemed stock opened at $540.89 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company has a market capitalization of $7.18 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 2.02 and a beta of 0.51. Chemed has a one year low of $365.20 and a one year high of $551.68. The company’s fifty day moving average price is $469.13 and its two-hundred day moving average price is $437.15.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, analysts forecast that Chemed will post 23.18 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.4%. Chemed’s payout ratio is presently 12.05%.

Insider Transactions at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares in the company, valued at $1,879,556. This trade represents a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of CHE. Legacy Wealth Asset Management LLC boosted its position in shares of Chemed by 25.8% in the second quarter. Legacy Wealth Asset Management LLC now owns 3,056 shares of the company’s stock valued at $1,423,000 after acquiring an additional 626 shares during the period. Sunburst Financial Group LLC increased its position in Chemed by 12.0% during the second quarter. Sunburst Financial Group LLC now owns 812 shares of the company’s stock worth $378,000 after acquiring an additional 87 shares during the period. First Heartland Consultants Inc. increased its position in Chemed by 14.5% during the second quarter. First Heartland Consultants Inc. now owns 1,404 shares of the company’s stock worth $654,000 after acquiring an additional 178 shares during the period. GAMMA Investing LLC raised its stake in Chemed by 149.0% during the 2nd quarter. GAMMA Investing LLC now owns 620 shares of the company’s stock valued at $289,000 after purchasing an additional 371 shares during the last quarter. Finally, Somerset Trust Co acquired a new position in Chemed during the 2nd quarter valued at $228,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.